CommercialAdministrativeLow impact
05.00.24s, Short-term Interstitial Continuous Glucose Monitoring Systems (CGMS)
Independence Blue Cross·Endocrinology, Family Medicine, Internal Medicine·Medical Policy
Effective date
Nov 12, 2025
We identified it
Jun 19, 2026
Summary
Policy 05.00.24s regarding Short-term Interstitial Continuous Glucose Monitoring Systems (CGMS) has been reissued for commercial plans. This is a reissue of an existing policy rather than new coverage changes, maintaining current billing and coverage guidelines for CGMS devices.
Action Required
By November 12, 2025: Billing team should review the reissued CGMS policy on the IBX medical policy portal to confirm no changes to current billing practices for short-term continuous glucose monitoring systems. Verify existing prior authorization and documentation requirements remain unchanged for commercial plans.